The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis
- PMID: 33402103
- PMCID: PMC7786920
- DOI: 10.1186/s12885-020-07749-6
The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis
Abstract
Background: Ataxia telangiectasia-mutated (ATM) gene contributes to repair damaged DNA and to regulate cell cycle; therefore, ATM variants seem to increase breast cancer risk; however, the results are controversial. So we conducted a systematic review and meta-analysis to clarify the pooled association between various ATM variants and the risk of breast cancer.
Methods: The relevant studies were searched through Scopus, Web of Science, PubMed and Cochrane. Stratified and subgroup analyses were performed to explore heterogeneity between studies and assess effects of study quality. The pooled estimates logarithm with standard error logarithm of odds ratio and relative risk with confidence interval were calculated.
Results: This study revealed that there is association between ATM variants and the risk of breast cancer; according to the seven adjusted case-control studies, OR of this association was estimated as 1.67 (95%CI: 0.73-3.82), according to nine unadjusted case-control studies, the crude OR was 2.27 (95% CI: 1.17-4.40) and according to two cohorts, the RR was estimated as 1.68 (95% CI: 1.17-2.40).
Conclusions: The ATM variants are associated with an increased risk of breast cancer that ATM V2424G mutation is detected as the most predisposing factor while ATM D1853V, L546V, and S707P variants have the least predictive ability.
Keywords: ATM; Breast cancer; Meta-analysis; Systematic review; Variant.
Conflict of interest statement
We declare that we have no conflict of interest.
Figures
References
-
- Moslemi M, et al. Expression analysis of EEPD1 and MUS81 genes in breast Cancer. 2020.
-
- Thorstenson YR, et al. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 2003;63(12):3325–3333. - PubMed
-
- Hirsch AE, Atencio DP, Rosenstein BS. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. Breast Cancer Res Treat. 2008;107(1):139–144. - PubMed
-
- Desmond A, et al. Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol. 2015;1(7):943–951. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
